AI assistant
Twist Bioscience Corp — Director's Dealing 2019
Aug 23, 2019
31873_dirs_2019-08-23_7dd63f7d-c142-48a6-9c71-bbff38fca585.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2019-08-22
Reporting Person: Weiss Patrick (SVP, R&D GM Data Storage)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-22 | Common Stock | S | 2700 | $29.033 | Disposed | 105587 | Direct |
| 2019-08-22 | Common Stock | S | 300 | $30.457 | Disposed | 105287 | Direct |
Footnotes
F1: Represents the aggregate of sales effected on the same day at different prices.
F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $28.68 to $29.64 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $30.41 to $30.52 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.